DataMEDS AI, Inc.
MEDS
$1.00
$0.033.43%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 8.02M | 14.03M | 23.34M | 34.08M | 36.74M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.02M | 14.03M | 23.34M | 34.08M | 36.74M |
| Cost of Revenue | 15.30M | 20.98M | 29.76M | 31.40M | 33.77M |
| Gross Profit | -7.27M | -6.95M | -6.43M | 2.68M | 2.97M |
| SG&A Expenses | 48.12M | 46.15M | 71.56M | 71.77M | 42.59M |
| Depreciation & Amortization | 2.32M | 2.77M | 3.21M | 3.06M | 2.72M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 65.73M | 69.90M | 104.53M | 106.22M | 79.08M |
| Operating Income | -57.71M | -55.86M | -81.19M | -72.14M | -42.34M |
| Income Before Tax | -88.28M | -76.59M | -101.27M | -77.75M | -45.30M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -88.28 | -76.59 | -101.27 | -77.75 | -45.30 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -88.28M | -76.59M | -101.27M | -77.75M | -45.30M |
| EBIT | -57.71M | -55.86M | -81.19M | -72.14M | -42.34M |
| EBITDA | -55.39M | -53.10M | -77.98M | -69.09M | -39.63M |
| EPS Basic | -48.32 | -46.59 | -74.13 | -64.14 | -43.00 |
| Normalized Basic EPS | -22.88 | -24.03 | -41.17 | -39.52 | -26.88 |
| EPS Diluted | -48.32 | -46.59 | -74.13 | -64.14 | -43.00 |
| Normalized Diluted EPS | -22.88 | -24.03 | -41.17 | -39.52 | -26.88 |
| Average Basic Shares Outstanding | 8.09M | 6.75M | 5.69M | 4.74M | 4.22M |
| Average Diluted Shares Outstanding | 8.09M | 6.75M | 5.69M | 4.74M | 4.22M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |